Vimarsana
Biggest News Aggregation in the World

Page 13 - Continuous Manufacturing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Continuous Manufacturing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Continuous Manufacturing Today - Breaking & Trending Today

CDC approves mix-and-match Covid-19 boosters - Vimarsana News

CDC approves mix-and-match Covid-19 boosters

The CDC green-lighted Covid-19 booster shots for certain groups, allowing those eligible their choice of brand.

Washington Healthcare Update - October 2021 #3 | McGuireWoods Consulting - Vimarsana News

Washington Healthcare Update - October 2021 #3 | McGuireWoods Consulting

This week in Washington: Debt ceiling measure signed by President Biden; default averted for at least a month. Discussions about budget reconciliation continue.

Anticancer Agent "Tazverik® Tablets 200mg" (Tazemetostat Hydrobromide) Launched In Japan For EZH2 Gene Mutation-Positive Follicular Lymphoma - Vimarsana News

Anticancer Agent "Tazverik® Tablets 200mg" (Tazemetostat Hydrobromide) Launched In Japan For EZH2 Gene Mutation-Positive Follicular Lymphoma

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that it has launched the anticancer agent EZH2 inhibitor “Tazverik® Tablets 200 mg” (tazemetostat hydrobromide), in Japan with the indication of relapsed or refractory EZH2 gene mutation-positive follicular lymphoma (only when standard ...

Speeding up clinical trials by making drug production local - Vimarsana News

Speeding up clinical trials by making drug production local

Snapdragon Chemistry, co-founded by MIT Professor Tim Jamison, uses deep knowledge in chemical manufacturing and automation to improve pharmaceutical company’s drug production capabilities.

Source: mit.edu
RheaVita raises €2.5m, looks to disrupt the freeze-drying market - Vimarsana News

RheaVita raises €2.5m, looks to disrupt the freeze-drying market

RheaVita, a company developing continuous freeze-drying technology for biopharma products, has closed a €2.5m (US$3.04m) Series A financing round.